TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
SVAR Life Science AB
Closing information (x1000 EUR)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
25,475
|
23,884
|
21,697 |
Financial expenses |
1,035
|
728
|
673 |
Earnings before taxes |
4,248
|
4,067
|
-3,442 |
EBITDA |
4,501
|
4,294
|
3,791 |
Total assets |
28,341
|
25,141
|
23,823 |
Current assets |
19,993
|
15,635
|
10,061 |
Current liabilities |
5,211
|
5,278
|
5,055 |
Equity capital |
21,124
|
17,493
|
14,739 |
- share capital |
26
![]() |
26
|
29 |
Employees (average) |
122
|
120
|
123 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
74.5%
|
69.6%
|
61.9% |
Turnover per employee |
209
|
199
|
176 |
Profit as a percentage of turnover |
16.7%
|
17.0%
|
-15.9% |
Return on assets (ROA) |
18.6%
|
19.1%
|
-11.6% |
Current ratio |
383.7%
|
296.2%
|
199.0% |
Return on equity (ROE) |
20.1%
|
23.2%
|
-23.4% |
Change turnover |
1,522
|
3,944
|
1,518 |
Change turnover % |
6%
|
20%
|
8% |
Chg. No. of employees |
2
|
-3
|
33 |
Chg. No. of employees % |
2%
|
-2%
|
37% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.